retatrutide dosing in trials ESC 2024: improves lipid and cardiovascular risk profile Phase II trial retatrutide clinical trial dosing frequency

Cooking with moringa is possible, too

Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery

These forward-looking statements can be identified by the use of forward-looking terminology, including the words anticipates, expects, intends, plans, decides, may, will, likely, potential, future, coming, hope, or should, or, in each case, their negative or other variations or comparable terminology

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Pajula S, Jyrnki J, Tukiainen E, Caravitis L, Koljonen V

Regarding clinical outcomes, exenatide did not significantly reduce the number of heavy drinking days compared with placebo in the overall sample